完整標題：
WHO approves Siam Bioscience’s AstraZeneca vaccine for emergency use
發稿單位：Thai PBS
發稿時間：2021.10.14
撰 稿 者：無
原文連結：https://bit.ly/2YQ0xN4
The World Health Organization (WHO) has approved Siam Bioscience Company
Limited, a Thai company, as a qualified production site for AstraZeneca
vaccine and added the company to its Emergency Use Listing (EUL).
A letter, dated October 11th, from Dr. Rogério Gaspar, director of the WHO’
s Regulation and Prequalification Department, addressed to Dr. Etleva
Kadilli, director of the Supply Division of UNICEF, reads as follows:
“We are pleased to inform you of the positive recommendation of an
alternative manufacturing site, Siam Bioscience Co., Ltd. , 99 Moo 4,
Banmai, Bangyai, Nonthaburi 11140, Thailand, for the AstraZeneca (COPVID-19
vaccine suspension for injection.
This site includes the manufacturing of drug substance and drug product.
This recommendation is based on the data reviewed by the WHO and the positive
opinion issued by the Australia Therapeutic GoodsAdministration (TGA), which
is the regulatory authority of record for this vaccine.
Therefore, Siam Bioscience Co., Ltd. is added to the list of alternative
manufacturing sites forAstraZeneca AB, as part of the EUL, granted to the
company.”
Wholly owned by a subsidiary of the Crown Property Bureau, Siam Bioscience
was established in 2009 to preserve and continue what the late King Bhumibol
Adulyadej started in support of the Thai people’s health and wellbeing.
Its main products are biopharmaceuticals, to reduce Thailand’s dependence on
imported active ingredients and medicines, strengthening public health and
facilitating sustainable health care.
In November 2020, Siam Bioscience, Siam Cement Group, AstraZeneca and Public
Health Ministry signed a letter of intent to commit to making COVID-19
vaccine available in Southeast Asia. A production agreement was subsequently
signed between AstraZeneca and Siam Bioscience.
Millions of doses of the AstraZeneca vaccine, produced by Siam Bioscience,
have already been delivered to the Ministry of Public Health.
AstraZeneca官網也有公告，這個緊急使用授權是立即生效的，不過WHO官網上的清單好像
還沒有更新就是了。
台灣目前也沒看到主流新聞媒體有相關報導，所以先貼泰國公共媒體的英文報導出來給大
家看。
之前有看到一些規定比較嚴格的國家會認產地，這次WHO把泰國產AZ疫苗列入EUL後，至少
能確定在台灣打到的AZ疫苗都是有WHO認證的，有出國需要的人應該會比較安心。